APA

Geers L. M., Pozhidaev I. V., Ivanova S. A., Freydin M. B., Schmidt A. F., Cohen D., Boyko A. S., Paderina D. Z., Fedorenko O. Y., Semke A. V., Bokhan N. A., Wilffert B., Kosterink J. G., Touw D. J. & Loonen A. J. M.Association between 8 P‐glycoprotein (MDR1/ABCB1) gene polymorphisms and antipsychotic drug‐induced hyperprolactinaemia. : .

Chicago

Geers L M, Pozhidaev I V, Ivanova S A, Freydin M B, Schmidt A F, Cohen D, Boyko A S, Paderina D Z, Fedorenko O Yu, Semke A V, Bokhan N A, Wilffert B, Kosterink J G.W, Touw D J and Loonen A J M.Association between 8 P‐glycoprotein (MDR1/ABCB1) gene polymorphisms and antipsychotic drug‐induced hyperprolactinaemia. : .

Harvard

Geers L. M., Pozhidaev I. V., Ivanova S. A., Freydin M. B., Schmidt A. F., Cohen D., Boyko A. S., Paderina D. Z., Fedorenko O. Y., Semke A. V., Bokhan N. A., Wilffert B., Kosterink J. G., Touw D. J. and Loonen A. J. M.Association between 8 P‐glycoprotein (MDR1/ABCB1) gene polymorphisms and antipsychotic drug‐induced hyperprolactinaemia. : .

MLA

Geers L M, Pozhidaev I V, Ivanova S A, Freydin M B, Schmidt A F, Cohen D, Boyko A S, Paderina D Z, Fedorenko O Yu, Semke A V, Bokhan N A, Wilffert B, Kosterink J G.W, Touw D J and Loonen A J M.: . .